In support of this finding, immunoblotting of tumor lysates from TNBC-related patient-derived xenograft (PDXs), showed that in TNBC setting, elevated CD74 expression positively correlates with the activation of AKT signaling pathway (Figure 2B). This evidence concerns the gene AKT1 and neoplasm.